Antitrust

Henry Schein Hid Anti-Competitive Agreements Securities Class Action

Henry Schein, Inc.’s Form 10-Q for the first quarter of 2013 said that “the health care industry has increasingly focused on cost containment” including through the growth of buying groups. But the company seems to have been determined not to give its customers what they wanted. The complaint for this securities class action alleges that  Read more

Inductors Price-Fixing and Antitrust Collusion Class Action

The US Department of Justice obtained guilty pleas in a recent antitrust case relating to makers of capacitors. Now comes a similar price-fixing case relating to makers of inductors, another type of electronic component, alleging violations of the Sherman Act. The complaint alleges that the defendants, who control 75% of the global market, colluded to  Read more

Silicone Wristbands and Other Promotional Goods Antitrust Class Action

The Department of Justice (DOJ) is investigating promotional wristbands—or the companies that make them. This class action grew out of that investigation, according to its complaint, which claims that from at least June 2014 to at least June 2016, the defendants used text messages, online messaging platforms, and in-person meetings to conspire to fix prices  Read more

Novartis Gleevec and Sun Generic Drug Antitrust Class Action

Can a company be sued for not bringing out a drug soon enough? The complaint for this class action alleges that the reason the drug was not promptly put on the market was an illegal anti-competitive agreement between two drug manufacturers. According to the complaint, Novartis and Sun entered into an anti-competitive agreement saying that  Read more

Containerboard Products Antitrust Settlement

Some defendants have agreed to settle a class action alleging that they violated antitrust laws by conspiring to fix or raise the price of containerboard products, such as by limiting supply. The category of “containerboard products” includes linerboard, corrugated medium, rollstock, corrugated sheets, and corrugated products, such as displays and boxes. Final approval was granted  Read more

Menactra Antitrust Litigation Settlement

Sanofi has agreed to settle a class action alleging that it engaged in antitrust behavior, preventing competition and forcing customers to pay higher prices than necessary for its Menactra vaccine. Novartis was launching a competitor vaccine, and the complaint alleges that Sanofi required health care providers to buy the vaccine from it or risk paying  Read more

Illinois Cathode Ray Tube Antitrust Settlement

Hitachi, LG Electronics, Philips, and Samsung have decided to settle an antitrust action brought by the State of Illinois for a total of about $36 million. The complaint alleged that the companies conspired to fix or maintain prices of cathode ray tubes (CRTs), which meant that consumers who bought TVs and monitors containing CRTs were  Read more

Silicone Wristband, Lanyard, and Button Antitrust Class Action

The complaint for this class action alleges that antitrust price-fixing in the business of selling and customizing the silicone wristbands for our favorite charities, the lanyards from which we hang our IDs and keys, and the pin buttons touting slogans or political candidates. Acording to the complaint, the market for these custom promotional products in  Read more

Endo International Concealed Par Pharmaceuticals Conduct Securities Class Action

Endo International plc develops pharmaceutical products and generic drugs, so its acquisition of Par Pharmaceutical Holdings, Inc., a maker of generic drugs, must have seemed like a profitable move. But the complaint claims Endo concealed information then and over the next many months: that Par had colluded to fix generic drug prices, that the “double-digit  Read more

Johnson & Johnson Remicade Anti-Competition Antitrust Class Action

In 2010, Congress enacted a Biologics Price Competition and Innovation Act to enable biosimilar drugs to receive approval, to spur price competition for drugs. However, the complaint for this class action alleges that when other companies developed competitors for Remicade, Johnson & Johnson (J&J) unfairly blocked their access to the market, with exclusivity contracts and  Read more